Xponance Inc. Boosts Stock Position in Biohaven Ltd. (NYSE:BHVN)
Xponance Inc. lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 25.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,148 shares of ...
Biotech stocks have been hit by ‘DOGE’ and other fears. Why they’re a great value now.
Investors’ deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approvals and M&A.
JD Supra3d
Why Compliance Audits Are Non-Negotiable
In today’s heightened enforcement environment, compliance auditing isn’t just a best practice—it’s a necessity. Federal and ...
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...
8,037 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Cibc World Markets Corp
Cibc World Markets Corp purchased a new stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) in the 4th quarter, ...